218 related articles for article (PubMed ID: 4677508)
21. Cardiovascular effects of intracisternal 6-hydroxydopamine and of subsequent lesions of the ventrolateral medulla coinciding with the Al group of noradrenaline cells in the rabbit.
Elliott JM; Stead BH; West MJ; Chalmers J
J Auton Nerv Syst; 1985; 12(2-3):117-30. PubMed ID: 3923089
[TBL] [Abstract][Full Text] [Related]
22. Modification and characterization of the permanent sympathectomy produced by the administration of guanethidine to newborn rats.
Johnson EM; O'Brien F; Werbitt R
Eur J Pharmacol; 1976 May; 37(1):45-54. PubMed ID: 6291
[TBL] [Abstract][Full Text] [Related]
23. 5-hydroxydopamine, unspecific centrally acting false neurotransmitter.
Brus R; Herman ZS; Szkilnik R; Dzikowski A; Opielka L; Bonczek A
Acta Physiol Pol; 1977; 28(1):13-21. PubMed ID: 868521
[TBL] [Abstract][Full Text] [Related]
24. Different effects of neonatal vinblastine on peripheral and central noradrenaline neurons.
Zieher LM; Jaim-Etcheverry G
Eur J Pharmacol; 1983 Sep; 93(1-2):101-6. PubMed ID: 6628544
[TBL] [Abstract][Full Text] [Related]
25. Effect of central early postnatal 6-hydroxydopamine administration on brain catecholamines and pituitary-adrenal function in adulthood.
Kaplanski J; Nyakas C; van Delft AM; Smelik PG
Neuroendocrinology; 1973-1974; 13(1):123-7. PubMed ID: 4779045
[No Abstract] [Full Text] [Related]
26. Correlation between central catecholamine level and post-decapitation convulsion in rats treated with 6-hydroxydopamine.
Suenaga N; Yamada K; Fukuda T
Brain Res; 1977 Feb; 122(1):165-9. PubMed ID: 837220
[No Abstract] [Full Text] [Related]
27. Actions of 6-hydroxydopamine quinones on catecholamine neurons.
Jonsson G; Sachs C
J Neurochem; 1975 Oct; 25(4):509-16. PubMed ID: 1173817
[No Abstract] [Full Text] [Related]
28. The effects of 6-hydroxydopamine and guanethidine on peripheral adrenergic nerves in the guinea pig.
O'Donnell SR; Saar N
Eur J Pharmacol; 1974 Oct; 28(2):251-6. PubMed ID: 4607945
[No Abstract] [Full Text] [Related]
29. Developmental plasticity of central noradrenaline neurons after neonatal damage--changes in transmitter functions.
Jonsson G; Wiesel FA; Hallman H
J Neurobiol; 1979 Jul; 10(4):337-53. PubMed ID: 224143
[TBL] [Abstract][Full Text] [Related]
30. Neonatal 6-hydroxydopamine treatment: noradrenaline levels and in vitro 3H-catecholamine synthesis in discrete brain regions of adult rats.
Versteeg DH; van Ree JM; Provoost AP; de Jong W
Life Sci; 1974 Dec; 15(12):2127-34. PubMed ID: 4621009
[No Abstract] [Full Text] [Related]
31. Resistance of central phenylethanolamine-n-methyl transferase containing neurons to 6-hydroxydopamine.
Jonsson G; Fuxe K; Hökfelt T; Goldstein M
Med Biol; 1976 Dec; 54(6):421-6. PubMed ID: 1004027
[TBL] [Abstract][Full Text] [Related]
32. Modulation of 6-hydroxydopamine induced alteration of the postnatal development of central noradrenaline neurons.
Jonsson G; Hallman H
Brain Res Bull; 1982; 9(1-6):635-40. PubMed ID: 6184133
[TBL] [Abstract][Full Text] [Related]
33. Vascular reactivity of rats after prevention of hypertension by central administration of 6-hydroxydopamine.
Haeusler G
J Hypertens Suppl; 1984 Dec; 2(3):S73-5. PubMed ID: 6443713
[TBL] [Abstract][Full Text] [Related]
34. Neonatal 6-hydroxydopamine treatment and the development of renal hypertension in the rat.
Kurnjek ML; Basso N; Taquini AC
Clin Exp Hypertens A; 1984; 6(5):1011-26. PubMed ID: 6428783
[TBL] [Abstract][Full Text] [Related]
35. Brain noradrenaline and the development of hypertension: the effect of treatment with central 6-hydroxydopamine or DSP-4.
van den Buuse M; Versteeq DH; de Jong W
Clin Exp Pharmacol Physiol; 1986 Jun; 13(6):469-76. PubMed ID: 3093124
[TBL] [Abstract][Full Text] [Related]
36. Effect of 6-hydroxydopamine on the level of the catecholamines in the brain of developing rats.
Brus R
Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):71-6. PubMed ID: 4717390
[No Abstract] [Full Text] [Related]
37. Proceedings: The recovery of vascular adrenergic nerve function in the rat after chemical sympathectomy with 6-hydroxydopamine.
Finch L; Haeusler G; Kuhn H; Thoenen H
Br J Pharmacol; 1972 Feb; 44(2):357P-358P. PubMed ID: 4668621
[No Abstract] [Full Text] [Related]
38. Neonatal sympathectomy by 6-hydroxydopamine in the rat: no effects on behavior by changes in endogenous brain norepinephrine.
Pappas BA; Sobrian SK
Life Sci I; 1972 Jul; 11(14):653-9. PubMed ID: 4656097
[No Abstract] [Full Text] [Related]
39. Changes in the development of central noradrenaline neurons after neonatal axon lesions.
Jonsson G; Sachs C
Brain Res Bull; 1982; 9(1-6):641-50. PubMed ID: 6816391
[TBL] [Abstract][Full Text] [Related]
40. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat.
Okuno T; Winternitz SR; Lindheimer MD; Oparil S
Am J Physiol; 1983 Jun; 244(6):H807-13. PubMed ID: 6407335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
